Rizaner and colleagues demonstrated that for robust metastatic rat prostate cancer Mat-LyLu cells, RAN (i) hindered Matrigel migration under both normoxic and hypoxic circumstances and (ii) decreased the proportion of cells in the lung metastases showing Nav1.7 [19]. Here, RAN is linked to prostate cancer.